Nicholas Mitsiades

24.2k citations
172 papers · 15.3k indexed · 5 hit papers · h-index 66
Topics
Multiple Myeloma Research and Treatments (40 papers)Cell death mechanisms and regulation (36 papers)Ubiquitin and proteasome pathways (31 papers)

In The Last Decade

Nicholas Mitsiades

169 papers receiving 14.9k citations

Hit Papers

NF-κB as a Therapeutic Target in Multiple Myeloma200220262010201820022002200320052002250500750

Peers

Nicholas Mitsiades
Comparison fields: 5 of 140
  • Molecular Biology 10.1k
  • Hematology 4.6k
  • Oncology 4.5k
  • Cancer Research 2.4k
  • Immunology 1.9k
Replace Constantine S. Mitsiades with:
Constantine S. Mitsiades United States
F Grignani Italy
Brett P. Monia United States
Paul Dent United States
Victoria M. Richon United States
Saverio Minucci Italy
Elisa de Stanchina United States
Bart Vanhaesebroeck United Kingdom
Steven Grant United States
Gary E. Gallick United States
Nicholas Mitsiades relative to Constantine S. Mitsiades United States Constantine S. Mitsiades's profile →
Citations per field
00.5×1.5×
Constantine S. Mitsiades · 1×
Citations per year

Countries citing papers authored by Nicholas Mitsiades

Since Specialization
Citations

This map shows the geographic impact of Nicholas Mitsiades's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Mitsiades with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Mitsiades more than expected).

Fields of papers citing papers by Nicholas Mitsiades

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Mitsiades. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Mitsiades. The network helps show where Nicholas Mitsiades may publish in the future.

Co-authorship network of co-authors of Nicholas Mitsiades

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Mitsiades. A scholar is included among the top collaborators of Nicholas Mitsiades based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Mitsiades. Nicholas Mitsiades is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 12
4 4
5 4
6 48
7 12
8 21
9 132
10 175
11 53
12 105
13 38
14 152
15 116
16
IGF-II is a major proliferative/anti-apoptotic cytokine and a therapeutic target in multiple myeloma, other hematologic neoplasias and solid tumors.
1
17
Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of b1-integrin and phosphatidylinositol 3-kinase/AKT signaling beta.
33
18 320
19 38
20 90

About Nicholas Mitsiades

Nicholas Mitsiades is a scholar working on Hematology, Cancer Research and Oncology, having authored 172 papers that have together received 15.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (40 papers), Cell death mechanisms and regulation (36 papers) and Ubiquitin and proteasome pathways (31 papers). The work is most often cited by research in Hematology (4.6k citations), Oncology (4.5k citations) and Cancer Research (2.4k citations). Nicholas Mitsiades has collaborated with scholars based in United States, Greece and Germany. Frequent co-authors include Constantine S. Mitsiades, Kenneth C. Anderson, Teru Hideshima, Vassiliki Poulaki, Nikhil C. Munshi, Paul G. Richardson, Dharminder Chauhan, Steven P. Treon, Robert Schlossman and Maria Tsokos. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026